natgillin/translations-raw huggingface dataset:
x) luua eraldi eelarverida, mis hõlbustaks viia kodanike tasandil läbi uimastipoliitika mõjusid käsitlevaid konsultatsioone vastavate kodanikuühiskonna organisatsioonide ja sõltumatute kutseliste asjatundjatega;
(x) create a specific budget line in order to facilitate an ongoing process of consultation with relevant civil-society organisations and independent professional experts about the impact of drug policies at the level of citizens;
y) luua hindamismeetmed, mis võimaldaksid aegsasti avastada puudusi ning leida sobivamaid meetmeid ja vahendeid ELi uimastistrateegias kehtestatud eesmärkide saavutamiseks;
(y) establish assessment measures which will allow shortcomings in - and more appropriate measures and resources to achieve - the goals set out in the EU Drugs Strategy to be detected correctly and rectified;
z) astuda asjakohaseid samme, et vältida ebaseaduslike ainetega kauplemisest saadud tulude kasutamist rahvusvahelise terrorismi rahastamiseks, ning kohaldada kaupade konfiskeerimist ja rahapesu vastu võitlemist käsitlevaid kehtivaid õigusakte;
(z) take appropriate steps to prevent the profits from illegal drug trafficking from being used to fund international terrorism and apply current legislation on confiscating goods and fighting money-laundering;
a a) viia kõikidesse rahvusvahelistesse kokkulepetesse ja eriti uutesse koostöökokkulepetesse kolmandate riikidega sisse uimastivastase koostöö eriklausel, millel oleks "olulise tähtsusega klausli" staatus;
(aa) include in all international agreements, and particularly new cooperation agreements with third countries, a specific anti-drug cooperation clause, with ‘essential clause’ status;
a b) suurendada oluliselt uimasteid tootvate riikide arenguabi võimalusi säästvate alternatiivsete põllukultuuride kasvatamise rahastamisprogrammide ja vaesuse järsu vähendamise abil; uurides samuti võimalusi, kuidas edendada ja kaitsta näiteks opiaatide tootmist meditsiiniliseks ja teaduslikuks otstarbeks, ning võtta arvesse kaitseprojektide alustamise võimalust seadusega lubatud ainete tööstuslikuks tootmiseks 1961. aasta konventsioonis loetletud taimedest, näiteks kokapuu lehtedest ja india kanepist;
(ab) significantly increase development aid to drug-producing countries, by means of programmes to fund sustainable alternative crops and the radical reduction of poverty, exploring also the possibility of promoting and safeguarding production for medical and scientific purposes, of opiates for example, and to take into consideration the possibility of launching pilot projects for the industrial manufacture of legal products derived from plants covered by the 1961 Convention, such as coca leaf and Indian hemp;
a c) tagada ja kindlustada ligipääs asendusprogrammidele, eriti vanglakeskkonnas, samal ajal soodustada ebaseaduslike ainete tarvitajate suhtes või ebaseaduslike ainete tarbimisega seotud väiksemate ja mittevägivaldsete süütegude eest vanglakaristuse asemel alternatiivsete karistusmeetodite rakendamist;
(ac) provide and ensure access to substitution programmes, with particular reference to the prison environment, while encouraging alternatives to imprisonment for users of illicit substances or for related minor and non-violent offences;
a d) laiendada teadusuuringuid selliste taimede nagu näiteks kanepi, oopiumimooni või kokapuu lehtede kohta, mis on hetkel ebaseaduslikud või siis kuuluvad halli tsooni, et neid saaks kasutada meditsiinis, toiduainetega kindlustamiseks, säästvas põllumajanduses, alternatiivsete energiaallikate loomiseks, puidu- või õlipõhiste ainete asendusaineteks ja teistel kasulikel eesmärkidel;
(ad) increase research into the use of plants that are currently illegal or in a grey zone, like hemp, opium or coca leaves, for medicinal applications, food security, sustainable agriculture, generation of alternative energy sources, substitution for tree- or oil-based products and other beneficial purposes;
a e) vaadata läbi uimastikaubandust käsitlev raamotsus ja võtta arvesse parlamendi väljendatud arvamused lepingutes sisalduvaid lähimuse ja proportsionaalsuse põhimõtteid arvesse võttes;
(ae) revise the framework decision on drug trafficking to take account of the views expressed by Parliament, with due regard for the principles of subsidiarity and proportionality enshrined in the Treaties;
a f) viia läbi teaduslik uurimus kehtivate narkootilisi aineid käsitlevate seaduste kulude ja tulude kohta, eriti: kanepi ja selle seaduslike ning ebaseaduslike derivaatide olemuse analüüs, muu hulgas hinnates ka nende mõju, potentsiaalseid raviomadusi ning kriminaalkaristuste rakendamise tulemusi ja nende võimalikke alternatiive; analüüs heroiini ravi eesmärkidel ja meditsiinilise järelevalve all manustamise programmide tõhususe kohta uimastite kasutamisest tingitud surmade vähendamisel; analüüs keelupoliitika majandus-, õigus-, sotsiaal- ja keskkonnaalaste kulude kohta, arvestades seaduse rakendamiseks vajalikke inim- ja rahalisi ressursse ja analüüs nii Euroopas strateegia kui ka ülemaailmse uimastite kontrolli strateegia kohaselt kehtiva poliitika mõju kohta mitteliikmesriikidele;
(af) carry out a scientific study into the costs and benefits of current policies for the control of narcotic substances, including, in particular: an analysis of cannabis and its various legal and illicit derivatives, inter alia to assess their effects, their therapeutic potential and the results of criminalisation policies and possible alternatives; an analysis of the effectiveness of programmes to distribute heroin under medical supervision for therapeutic purposes in terms of the objective of reducing drug-related deaths; an analysis of the economic, legal, social and environmental costs of prohibition policies in terms of the human and financial resources required to enforce the law; and an analysis of the impact on non-member countries of current policies under both the European Strategy and the global drug control system;
a g) innustada valitsusi ja riikide parlamente kasutusele võtma tõhusaid meetmeid, et vältida uimastite jõudmist vanglasse;
(ag) urge governments and national parliaments to take effective measures to prevent drugs entering prisons;
The EU's anti-drugs strategy must be based not on ideology but on scientific assessments, which must be taken as a starting point for any serious policy designed to combat the spread of drugs and related illegal activities.
The EU's anti-drugs strategy must be based not on ideology but on scientific assessments, which must be taken as a starting point for any serious policy designed to combat the spread of drugs and related illegal activities.
Narcotics consumption is on the increase within Europe and this constitutes the clearest evidence that the repressive, prohibitionist policies pursued by the EU Member States are powerless to combat the drugs trade, which continues to be one of the most important sources of income for organised crime and terrorist organisations.
Narcotics consumption is on the increase within Europe and this constitutes the clearest evidence that the repressive, prohibitionist policies pursued by the EU Member States are powerless to combat the drugs trade, which continues to be one of the most important sources of income for organised crime and terrorist organisations.
According to a study involving 7600 young people (aged between 15 and 24) which was carried out in April/May 2004 by Eurobarometer on behalf of the Commission, obtaining drugs is very easy in all European countries and the main reasons for consuming such substances are curiosity and the thrill of breaking society's rules.
According to a study involving 7600 young people (aged between 15 and 24) which was carried out in April/May 2004 by Eurobarometer on behalf of the Commission, obtaining drugs is very easy in all European countries and the main reasons for consuming such substances are curiosity and the thrill of breaking society's rules.
In particular, data contained in the Lisbon Monitoring Centre's 2003 annual report indicate that 'cannabis remains the most commonly used drug in the EU, with many countries reporting lifetime prevalence rates in excess of 20 % of the general population.
In particular, data contained in the Lisbon Monitoring Centre's 2003 annual report indicate that 'cannabis remains the most commonly used drug in the EU, with many countries reporting lifetime prevalence rates in excess of 20 % of the general population.
A conservative estimate would suggest that at least one in every five adults in the EU has tried the drug.
A conservative estimate would suggest that at least one in every five adults in the EU has tried the drug.
Indicators suggest that cannabis use has been increasing across the EU, although this increase appears to have stabilised in some countries, albeit at what can generally be considered to be historically high levels.'
Indicators suggest that cannabis use has been increasing across the EU, although this increase appears to have stabilised in some countries, albeit at what can generally be considered to be historically high levels.'
Generalisations must therefore be avoided when drugs are classified, since not all narcotic substances have the same effects and - as scientific studies have shown - certain substances (in particular, so-called 'light drugs') are not addictive.
Generalisations must therefore be avoided when drugs are classified, since not all narcotic substances have the same effects and - as scientific studies have shown - certain substances (in particular, so-called 'light drugs') are not addictive.
The other factor - in addition to the increase in the use of narcotics - which should be taken into account in the EU's strategy is the mortality relating to narcotics use: the number of AIDS-related deaths is falling, whilst the number of deaths caused by a drugs overdose is stable or is still increasing.
The other factor - in addition to the increase in the use of narcotics - which should be taken into account in the EU's strategy is the mortality relating to narcotics use: the number of AIDS-related deaths is falling, whilst the number of deaths caused by a drugs overdose is stable or is still increasing.
This is another statistic which illustrates the inescapable fact that the current strategy is failing to achieve the objectives of protecting individuals and improving the well-being of society.
This is another statistic which illustrates the inescapable fact that the current strategy is failing to achieve the objectives of protecting individuals and improving the well-being of society.
The current anti-drugs strategy leaves criminal and terrorist mafias and organisations quite unperturbed; if anything, their annual turnover is increasing as they reap the profits of the drugs trade.
The current anti-drugs strategy leaves criminal and terrorist mafias and organisations quite unperturbed; if anything, their annual turnover is increasing as they reap the profits of the drugs trade.
According to Europol the overall statistics reveal that drugs seizures are concentrated in just a few countries, which account for approximately 75% of all seizures carried out in the world in respect of any type of illegal drug.
According to Europol the overall statistics reveal that drugs seizures are concentrated in just a few countries, which account for approximately 75% of all seizures carried out in the world in respect of any type of illegal drug.
According to the Europol report on organised crime, drugs production and trafficking continue to be the main activity pursued by criminal groups in the EU.
According to the Europol report on organised crime, drugs production and trafficking continue to be the main activity pursued by criminal groups in the EU.
No other field of organised crime is quite so profitable.
No other field of organised crime is quite so profitable.
Drugs-related crime may be considered to include contravention of drugs legislation, offences committed under the influence of illegal drugs and offences committed by drug addicts in order to finance their habit (mainly housebreaking and shoplifting), together with 'systemic' crimes committed in connection with the functioning of illegal markets ('turf wars', corruption of officials, and so on).
Drugs-related crime may be considered to include contravention of drugs legislation, offences committed under the influence of illegal drugs and offences committed by drug addicts in order to finance their habit (mainly housebreaking and shoplifting), together with 'systemic' crimes committed in connection with the functioning of illegal markets ('turf wars', corruption of officials, and so on).
For these reasons a Community project should be launched for the purpose of introducing alternative forms of detention, so that drugs repression ceases to focus exclusively on imprisonment.
For these reasons a Community project should be launched for the purpose of introducing alternative forms of detention, so that drugs repression ceases to focus exclusively on imprisonment.
The anti-drugs strategy should be regarded as a form of social intervention concentrating on the reasons for social unrest with a view to preventing drugs use by refining a strategy of repression which is currently targeted solely at drug users.
The anti-drugs strategy should be regarded as a form of social intervention concentrating on the reasons for social unrest with a view to preventing drugs use by refining a strategy of repression which is currently targeted solely at drug users.
Hence the damage-reduction strategy must be given priority.
Hence the damage-reduction strategy must be given priority.
Measures designed to minimise drugs-related damage to health, to reduce the number of deaths and to subdue any breach of the peace have become an integral part of many of the Member States' drugs strategies and a clear political priority in most countries.
Measures designed to minimise drugs-related damage to health, to reduce the number of deaths and to subdue any breach of the peace have become an integral part of many of the Member States' drugs strategies and a clear political priority in most countries.
The implementation of initiatives designed to reduce damage is described in the Member States' literature on the subject as 'very important', 'highly significant', 'fundamental', ' priority' and 'a key aspect of our national drugs strategy'.
The implementation of initiatives designed to reduce damage is described in the Member States' literature on the subject as 'very important', 'highly significant', 'fundamental', ' priority' and 'a key aspect of our national drugs strategy'.
NÕUKOGULE ESITATAVA SOOVITUSE ETTEPANEK ( B6-0070/2004 )
PROPOSAL FOR A RECOMMENDATION TO THE COUNCIL ( B6-0070/2004 )
Esitaja: Rosa M. Díez González PSE fraktsiooni nimel
by Rosa M. Díez González, on behalf of the PSE Group
Teema: ELi uimastistrateegia (2005–2012) projekt
on the draft EU drugs strategy (2005-2012)
– võttes arvesse justiits- ja siseküsimuste nõukogu 2. ja 3. detsembri 2004. aasta kohtumist, millel arutatakse ELi uimastistrateegiat perioodiks 2005–2012;
– having regard to the meeting of the JHA Council of 2 and 3 December 2004, at which a draft EU drugs strategy for the period 2005-2012 is to be considered,
– võttes arvesse 17. detsembri 2004. aasta Euroopa Ülemkogu, millel peaks vastu võetama ELi uimastistrateegia perioodiks 2005–2012;
– having regard to the European Council of 17 December 2004, at which the draft EU drugs strategy for the period 2005-2012 is to be adopted,
– võttes arvesse kodukorra artikli 114 lõiget 1;
– having regard to Rule 114(1) of its Rules of Procedure,
A. arvestades, et uues ELi uimastistrateegias kehtestatud raamistik ja prioriteedid on aluseks kahele järjestikusele kolmeaastasele ELi uimastitevastasele tegevuskavale (2005–2007 ja 2009–2011), millest mõlemale järgneb üheaastane hindamisperiood (2008 ja 2012);
A. whereas the framework and the priorities laid down in the new EU drugs strategy are to serve as a basis for two consecutive three‑year EU action plans to combat drugs (2005-2007 and 2009-2011), each to be followed by a one-year period of evaluation (2008 and 2012),
B. arvestades, et ELi uimastipoliitika esmatähtis aspekt on ELi institutsioonide vahelise koostöö tõhustamine;
B. whereas an essential aspect of drugs policy within the EU consists in improving cooperation between EU institutions,
C. arvestades, et on oluline kasutada ära avanenud võimalust edendada ja arendada tõhusat ning laiaulatuslikku poliitikat uimastite vastu võitlemiseks;
C. whereas it is important to seize this opportunity to encourage and develop effective, comprehensive policies to combat drugs,
a) luua Euroopa uimastitevastase võitluse strateegia, mis keskendub pakkumise ja nõudluse vähendamisele ning teabe ja hindamise pakkumisele;
a) establish a genuine European policy to combat drugs, focused on reducing supply and demand, and on the provision of information and evaluation;
b) edendada ja arendada kahjude vähendamise poliitikat liikmesriikides, ilma et see takistaks liikmesriikidel võtta nimetatud valdkonnas asjakohaseid meetmeid või viia läbi katseprojekte;
b) encourage and develop damage-reduction policies in the Member States, without preventing individual Member States from adopting measures or conducting pilot schemes in this area;
c) kontrollida rangelt rahvusvahelistes kokkulepetes sätestatud uimastitevastast võitlust puudutava klausli järgimist ning nõuda sellele "olulise tähtsusega klausli" staatuse andmist;
c) strictly verify compliance with the clause relating to combating drugs in international agreements and, to that effect, ask that 'essential clause' status be accorded;
d) jälgida, et Euroopa Komisjon koostaks uimastitevastase võitluse tegevuskavad (2005–2007 ja 2009–2011) koostöös Euroopa Parlamendi, Narkootikumide ja Narkomaania Euroopa Järelevalvekeskuse (EMCDDA) ja Europoliga ning konsulteerides asjassepuutuvate kodanikuühiskonna organisatsioonidega;
d) see to it that the draft action plans to combat drugs (2005-2007 and 2009-2011) are drawn up by the Commission in cooperation with the European Parliament, the EMCDDA and Europol and in consultation with relevant civil society organisations;
Euroopa uimastitevastase võitluse strateegia (2005–2012)
European strategy on fighting drugs (2005-2012)
art 114 lg 3
Article 114(3)
Vastutav komisjon Teada andmise kuupäev
Committee responsible Date of announcement of authorisation in plenary
Nõuandev komisjon Teada andmise kuupäev
Committee(s) asked for opinion(s) Date announced in plenary
Tõhustatud koostöö Teada andmise kuupäev
Enhanced cooperation Date announced in plenary
Raportile lisatud resolutsiooni ettepanek
Motion for a resolution included in the report
Raportöör Nimetamise kuupäev
Rapporteur Date appointed
Lõpphääletuse ajal kohal olnud liikmed
Members present
Lõpphääletuse ajal kohal olnud asendusliikmed
Substitutes present
Lõpphääletuse ajal kohal olnud asendusliikmed (art 178 lg 2)
Rule 178(2) substitutes present
7.12.2004 A6-0067/2004
7.12.2004 A6-0067/2004
Teema: Euroopa Liidu 2005. eelarveaasta üldeelarve nõukogu muudatustega projekt(kõik eelarveosad)
on the draft general budget of the European Union for the financial year 2005 as modified by the Council (all sections)
Euroopa Liidu 2005. eelarveaasta üldeelarve projekti muutmiskirjad nr 1/2005 (15180/2004 – C6‑0216/2004), 2/2005 (15181/2004 – C6‑0217/2004) ja 3/2005 (15182/2004 – C6‑0218/2004)
and Letters of amendment Nos 1/2005 (15180/2004 – C6‑0216/2004), 2/2005 (15181/2004 – C6‑0217/2004) and 3/2005 (15182/2004 – C6‑0218/2004) to the draft general budget of the European Union for the financial year 2005
II eelarveosa – Euroopa Liidu Nõukogu
Section II – Council
III eelarveosa – Euroopa Komisjon
Section III – Commission
VI eelarveosa – Euroopa Majandus- ja Sotsiaalkomitee
Section VI – European Economic and Social Committee
Salvador Garriga Polledo (III eelarveosa – Euroopa Komisjon)
Salvador Garriga Polledo (Section III – Commission)
Anne Elisabet Jensen (teised eelarveosad)
Anne Elisabet Jensen (Other sections)
Euroopa Liidu 2005. eelarveaasta üldeelarve nõukogu muudatustega projekti (kõik eelarveosad) (11445/2004 – C6‑0123/2004 – 2004/2001(BUD) – 2004/2002(BUD) ) ning Euroopa Liidu 2005. eelarveaasta üldeelarve projekti muutmiskirjade nr 1/2005 (15180/2004 – C6‑0216/2004 ), 2/2005 (15181 – C6‑0217/2004 ) ja 3/2005 (15182 – C6‑0218/2004 ) kohta
on the draft general budget of the European Union for the financial year 2005, as modified by the Council (all sections) (11445/2004 – C6‑0123/2004 – 2004/2001(BUD) – 2004/2002(BUD) ) and Letters of amendment Nos 1/2005 (15180/2004 – C6‑0216/2004 ), 2/2005 (15181/2004 – C6‑0217/2004 ) and 3/2005 (15182/2004 – C6‑0218/2004 ) to the draft general budget of the European Union for the financial year 2005
– võttes arvesse Euroopa Ühenduse asutamislepingut, eelkõige selle artikli 272 lõike 4 eelviimast lõiku;
– having regard to the Treaty establishing the European Community, and in particular Article 272(4), penultimate paragraph thereof,
– võttes arvesse Euroopa Aatomienergiaühenduse asutamislepingut, eelkõige selle artiklit 177;
– having regard to the Treaty establishing the European Atomic Energy Community, and in particular Article 177 thereof,
– võttes arvesse 6. mai 1999. a Euroopa Parlamendi, nõukogu ja Euroopa Komisjoni vahel sõlmitud institutsioonidevahelist kokkulepet eelarvedistsipliini ja eelarvemenetluse parandamise kohta
– having regard to the Interinstitutional Agreement of 6 May 1999 between the European Parliament, the Council and the Commission on budgetary discipline and improvement of the budgetary procedure
– võttes arvesse Euroopa Liidu 2005. eelarveaasta üldeelarve esialgset projekti, mille nõukogu koostas 16. juulil 2005. a ( C6‑0123/2004 );
– having regard to the draft general budget of the European Union for the financial year 2005, which the Council established on 16 July 2005 ( C6-0123/2004 ),
– võttes arvesse parlamendi 28. oktoobri 2004. a resolutsiooni Euroopa Liidu 2005. eelarveaasta üldeelarve projekti kohta, III eelarveosa – Euroopa Komisjon ( C6-0123/2004 )
– having regard to its resolution of 28 October 2004 on the draft general budget of the European Union for the financial year 2005, Section III - Commission ( C6-0123/2004 )
– võttes arvesse parlamendi 28. oktoobri 2004 a. resolutsiooni Euroopa Liidu 2005. eelarveaasta üldeelarve projekti I eelarveosa (Euroopa Parlament), II eelarveosa (nõukogu), IV eelarveosa (Euroopa Kohus), V eelarveosa (kontrollikoda), VI eelarveosa (Euroopa Majandus- ja Sotsiaalkomitee), VII eelarveosa (Regioonide komitee), VIII (A) eelarveosa (Euroopa Ombudsman) ja VIII (B) eelarveosa (Euroopa Andmekaitseinspektor) kohta ( C6-0123/2004 )
– having regard to its resolution of 28 October 2004 on the draft general budget of the European Union for the financial year 2005, Section I - European Parliament, Section II - Council, Section IV - Court of Justice, Section V - Court of Auditors, Section VI - Economic and Social Committee, Section VII - Committee of the Regions, Section VIII(A) - European Ombudsman, Section VIII(B) - European Data Protection Supervisor ( C6-0123/2004 )
– võttes arvesse parlamendi muudatusettepanekuid ja 28. oktoobril 2004. a esitatud muudatusi üldeelarve projekti kohta;
– having regard to its amendments and proposed modifications of 28 October 2004 to the draft general budget,
– võttes arvesse nõukogu muudatusi muudatusettepanekutes ja parlamendi poolt vastu võetud üldeelarve projekti muudatuste ettepanekuid (11445/2004 - C6-0123/2004 );
– having regard to the Council's modifications to the amendments and proposed modifications adopted by Parliament to the draft general budget (11445/2004 - C6-0123/2004 ),
– võttes arvesse 25. novembri 2004. a lepitusmenetluse tulemusi;
– having regard to the results of the conciliation of 25 November 2004,
– võttes arvesse parlamendi otsust 6. mai 1999. a institutsioonidevahelise kokkuleppe lõikes 24 sätestatud paindlikkusinstrumendi rakendamise kohta;
– having regard to its decision to mobilise the flexibility instrument provided for in paragraph 24 of the Interinstitutional Agreement (IIA) of 6 May 1999,
– võttes arvesse eelarvekomisjoni raportit ( A6-0068/2004 );
– having regard to the report of the Committee on Budgets ( A6-0068/2004 ),